Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Luigi Meroni

Showing results (131-140 of 276) with videos related to

Pageof 28
Sort By:
Arthritis Research & Therapy|December 17, 2005
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective studyFabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, et al.
British Journal of Haematology|June 29, 2005
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammationMassimo Cugno, Piergiuseppe Agostoni, Daniela Mari, et al.
Journal of Clinical Medicine|July 12, 2020
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot StudyDaniela Greco, Roberta Gualtierotti, Pasquale Agosti, et al.
Frontiers in Immunology|February 13, 2016
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus ErythematosusMaria Gerosa, Barbara Poletti, Francesca Pregnolato, et al.
Arthritis Research & Therapy|November 10, 2020
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosisElena Raschi, Daniela Privitera, Caterina Bodio, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 25, 2011
Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid AntibodiesSilvia S Pierangeli, Emmanuel J Favaloro, Gabriella Lakos, et al.
Arthritis Care & Research|April 15, 2010
Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic diseaseIvana Hollan, Barbara Bottazzi, Ivan Cuccovillo, et al.
Rheumatology (Oxford, England)|October 6, 2018
Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert ConsensusAlessandra Bortoluzzi, Guido Valesini, Salvatore D'Angelo, et al.
Autoimmunity Reviews|September 15, 2007
AutoAbSC.Org -- Autoantibody Standardization Committee in 2006Edward K L Chan, Marvin J Fritzler, Allan Wiik, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritisGabriella Moroni, Donatella Ventura, Paola Riva, et al.
Pageof 28

Showing results (131-140 of 276) with videos related to

Sort By:
Pageof 28
Arthritis Research & Therapy|December 17, 2005
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective studyFabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, et al.
British Journal of Haematology|June 29, 2005
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammationMassimo Cugno, Piergiuseppe Agostoni, Daniela Mari, et al.
Journal of Clinical Medicine|July 12, 2020
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot StudyDaniela Greco, Roberta Gualtierotti, Pasquale Agosti, et al.
Frontiers in Immunology|February 13, 2016
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus ErythematosusMaria Gerosa, Barbara Poletti, Francesca Pregnolato, et al.
Arthritis Research & Therapy|November 10, 2020
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosisElena Raschi, Daniela Privitera, Caterina Bodio, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 25, 2011
Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid AntibodiesSilvia S Pierangeli, Emmanuel J Favaloro, Gabriella Lakos, et al.
Arthritis Care & Research|April 15, 2010
Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic diseaseIvana Hollan, Barbara Bottazzi, Ivan Cuccovillo, et al.
Rheumatology (Oxford, England)|October 6, 2018
Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert ConsensusAlessandra Bortoluzzi, Guido Valesini, Salvatore D'Angelo, et al.
Autoimmunity Reviews|September 15, 2007
AutoAbSC.Org -- Autoantibody Standardization Committee in 2006Edward K L Chan, Marvin J Fritzler, Allan Wiik, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritisGabriella Moroni, Donatella Ventura, Paola Riva, et al.
Pageof 28